Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [520]
News [1466]
Articles [67]
Editorials [2]
Conferences [72]
elearning [5]
Treating ALL patients during the COVID-19 pandemic
Prof David Marks - University hospital Bristol NHS Foundation Trust, Bristol, UK
Treating ALL patients during the COVID-19 pandemic ( Prof David Marks - University hospital Bristol NHS Foundation Trust, Bristol, UK )
15 Oct 2020
OncoAlert and ecancer weekly roundup for October 5th - October 11th, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for October 5th - October 11th, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
12 Oct 2020
ESMO 2020 melanoma roundup
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
ESMO 2020 melanoma roundup ( Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany )
28 Sep 2020
Lenvatinib plus pembrolizumab for advanced melanoma that progressed on a PD-1...
Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain
Lenvatinib plus pembrolizumab for advanced melanoma that progressed on a PD-1 or PD-L1 inhibitor: initial results of LEAP-004 ( Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain )
22 Sep 2020
OncoAlert and ecancer weekly roundup for August 30 - September 5 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for August 30 - September 5 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
7 Sep 2020
OncoAlert and ecancer weekly roundup for August 1-8 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for August 1-8 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
17 Aug 2020
COMBI-AD trial: Adjuvant dabrafenib plus trametinib in patients with resected...
Prof Axel Hauschild - University Hospital, Schleswig-Holstein, Germany
COMBI-AD trial: Adjuvant dabrafenib plus trametinib in patients with resected stage III BRAF V600–mutant melanoma ( Prof Axel Hauschild - University Hospital, Schleswig-Holstein, Germany )
30 Jun 2020
IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients...
Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia
IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma ( Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia )
1 May 2020
Continuous vs intermittent dosing of dabrafenib and trametinib in BRAF mutated...
Prof Alain Algazi -University of California San Francisco, San Francisco, USA
Continuous vs intermittent dosing of dabrafenib and trametinib in BRAF mutated melanoma ( Prof Alain Algazi -University of California San Francisco, San Francisco, USA )
30 Apr 2020
Where have we got to with cancer treatment?
Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology...
Where have we got to with cancer treatment? ( Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands )
27 Jan 2020
The treatment landscape of occular melanoma
Maitry Patel CCPA - Princess Margaret Cancer Centre, Toronto, Canada
The treatment landscape of occular melanoma ( Maitry Patel CCPA - Princess Margaret Cancer Centre, Toronto, Canada )
21 Oct 2019
IMspire170: New combination treatment for advanced melanoma
Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain
IMspire170: New combination treatment for advanced melanoma ( Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain )
7 Oct 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation